financetom
Business
financetom
/
Business
/
Waymo brings its cars to NYC for testing, applies for autonomous driving permit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Waymo brings its cars to NYC for testing, applies for autonomous driving permit
Jun 18, 2025 11:47 AM

(Reuters) -Alphabet's self-driving unit Waymo said on Wednesday its vehicles will be back in New York City next month for autonomous testing, as it continues to scale operations in the U.S.

The race to deploy robotaxis is picking up pace as Waymo expands testing and Tesla prepares to begin limited trials of its autonomous taxi service with as few as 10 cars this weekend - a sign of growing momentum in self-driving vehicle development.

Waymo has applied for a permit from the New York City Department of Transportation to operate autonomously, with a trained specialist behind the wheel in Manhattan. 

"This is not an expansion, but we have every intention of bringing our fully autonomous ride-hailing service to the city in the future," Waymo said.

Waymo will start by manually driving in the city until it gets the permit. If granted, it would be New York City's first testing deployment of autonomous vehicles.

New York State law does not currently allow operating a vehicle with no human behind the wheel and Waymo said it is advocating for a change to the law.

The company had previously brought its cars to Manhattan in 2021 for manual driving, data collection and testing.

Waymo on Tuesday said it will expand into more areas of the San Francisco peninsula and parts of Silicon Valley. Last month, it received approval from California to expand operations.

As the only U.S. firm to run robotaxi services with paying passengers, Waymo has more than 1,500 vehicles, running over 250,000 rides a week across San Francisco and Los Angeles in California, Phoenix in Arizona and Austin in Texas.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alphabet Tends to Reverse or Narrow Post-Market Earnings Moves in Follow-On Regular Session
Alphabet Tends to Reverse or Narrow Post-Market Earnings Moves in Follow-On Regular Session
Apr 25, 2024
07:00 AM EDT, 04/25/2024 (MT Newswires) -- Alphabet (GOOGL, GOOG) is due with its Q1 results in the after-hours today. Analysts polled by Capital IQ expect the company to post a profit of $1.50 per share on revenue of $78.7 billion. GOOGL has recorded an earnings-driven after-hours decline in 32 of the last 78 quarters we've tracked, and in 14...
Sanofi Q1 Earnings Fall, Net Sales Climb
Sanofi Q1 Earnings Fall, Net Sales Climb
Apr 25, 2024
07:01 AM EDT, 04/25/2024 (MT Newswires) -- Sanofi ( SNY ) reported Q1 non-IFRS business earnings Thursday of 1.78 euros ($1.90) per share, down from 2.16 euros a year earlier. An analyst polled by Capital IQ expected 1.71 euros. Net sales for the quarter were 10.46 million euros, up from 10.22 million euros a year earlier. Analysts polled by Capital...
Merck Non-GAAP Earnings, Sales Rise; 2024 Guidance Raised
Merck Non-GAAP Earnings, Sales Rise; 2024 Guidance Raised
Apr 25, 2024
07:00 AM EDT, 04/25/2024 (MT Newswires) -- Merck ( MRK ) reported Q1 non-GAAP earnings Thursday of $2.07 per share, up from $1.40 a year ago. Analysts polled by Capital IQ expected $1.92. Sales for the quarter ended March 31 were $15.78 billion, up from $14.49 billion a year earlier. Analysts surveyed by Capital IQ expected $15.20 billion. For 2024,...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Apr 25, 2024
April 25 (Reuters) - Merck & Co ( MRK ) on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine Gardasil. The New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous prediction of $8.44 to $8.59,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved